Lördag 20 Juni | 04:07:46 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2027-01-26 08:00 Bokslutskommuniké 2026
2026-10-20 12:00 Kvartalsrapport 2026-Q3
2026-07-17 12:00 Kvartalsrapport 2026-Q2
2026-04-22 - X-dag ordinarie utdelning GETI B 4.75 SEK
2026-04-21 - Årsstämma
2026-04-21 - Kvartalsrapport 2026-Q1
2026-01-27 - Bokslutskommuniké 2025
2025-10-21 - Kvartalsrapport 2025-Q3
2025-07-18 - Kvartalsrapport 2025-Q2
2025-04-23 - X-dag ordinarie utdelning GETI B 4.60 SEK
2025-04-22 - Årsstämma
2025-04-22 - Kvartalsrapport 2025-Q1
2025-01-28 - Bokslutskommuniké 2024
2024-10-18 - Kvartalsrapport 2024-Q3
2024-07-18 - Kvartalsrapport 2024-Q2
2024-04-23 - X-dag ordinarie utdelning GETI B 4.40 SEK
2024-04-22 - Årsstämma
2024-04-22 - Kvartalsrapport 2024-Q1
2024-02-01 - Bokslutskommuniké 2023
2023-10-23 - Kvartalsrapport 2023-Q3
2023-07-18 - Kvartalsrapport 2023-Q2
2023-04-27 - X-dag ordinarie utdelning GETI B 4.25 SEK
2023-04-26 - Årsstämma
2023-04-26 - Kvartalsrapport 2023-Q1
2023-02-01 - Bokslutskommuniké 2022
2022-10-19 - Kvartalsrapport 2022-Q3
2022-07-19 - Kvartalsrapport 2022-Q2
2022-04-27 - X-dag ordinarie utdelning GETI B 4.00 SEK
2022-04-26 - Årsstämma
2022-04-26 - Kvartalsrapport 2022-Q1
2022-01-28 - Bokslutskommuniké 2021
2021-10-20 - Kvartalsrapport 2021-Q3
2021-07-16 - Kvartalsrapport 2021-Q2
2021-04-21 - X-dag ordinarie utdelning GETI B 3.00 SEK
2021-04-20 - Årsstämma
2021-04-20 - Kvartalsrapport 2021-Q1
2021-01-28 - Bokslutskommuniké 2020
2020-10-16 - Kvartalsrapport 2020-Q3
2020-07-16 - Kvartalsrapport 2020-Q2
2020-06-29 - X-dag ordinarie utdelning GETI B 1.50 SEK
2020-06-26 - Årsstämma
2020-04-22 - Kvartalsrapport 2020-Q1
2020-01-30 - Bokslutskommuniké 2019
2019-10-18 - Kvartalsrapport 2019-Q3
2019-07-17 - Kvartalsrapport 2019-Q2
2019-04-24 - X-dag ordinarie utdelning GETI B 1.00 SEK
2019-04-23 - Årsstämma
2019-04-23 - Kvartalsrapport 2019-Q1
2019-01-30 - Bokslutskommuniké 2018
2018-10-18 - Kvartalsrapport 2018-Q3
2018-07-17 - Kvartalsrapport 2018-Q2
2018-04-27 - X-dag ordinarie utdelning GETI B 1.50 SEK
2018-04-26 - Årsstämma
2018-04-26 - Kvartalsrapport 2018-Q1
2018-01-29 - Bokslutskommuniké 2017
2017-10-18 - Kvartalsrapport 2017-Q3
2017-07-17 - Kvartalsrapport 2017-Q2
2017-04-25 - Kvartalsrapport 2017-Q1
2017-03-30 - X-dag ordinarie utdelning GETI B 2.00 SEK
2017-03-29 - Årsstämma
2017-01-26 - Bokslutskommuniké 2016
2016-10-18 - Kvartalsrapport 2016-Q3
2016-07-14 - Kvartalsrapport 2016-Q2
2016-04-22 - Kvartalsrapport 2016-Q1
2016-03-31 - X-dag ordinarie utdelning
2016-03-30 - Årsstämma
2016-01-28 - Bokslutskommuniké 2015
2015-10-15 - Kvartalsrapport 2015-Q3
2015-09-02 - Extra Bolagsstämma 2015
2015-07-15 - Kvartalsrapport 2015-Q2
2015-04-20 - Kvartalsrapport 2015-Q1
2015-03-26 - X-dag ordinarie utdelning GETI B 2.80 SEK
2015-03-25 - Årsstämma
2015-01-28 - Bokslutskommuniké 2014
2014-10-16 - Analytiker möte 2014
2014-10-16 - Kvartalsrapport 2014-Q3
2014-07-15 - Kvartalsrapport 2014-Q2
2014-04-16 - Kvartalsrapport 2014-Q1
2014-03-21 - X-dag ordinarie utdelning GETI B 4.15 SEK
2014-03-20 - Årsstämma
2014-01-28 - Bokslutskommuniké 2013
2013-10-15 - Analytiker möte 2013
2013-10-15 - 15-7 2013
2013-10-15 - Kvartalsrapport 2013-Q3
2013-07-11 - Kvartalsrapport 2013-Q2
2013-04-17 - Kvartalsrapport 2013-Q1
2013-03-22 - X-dag ordinarie utdelning GETI B 4.15 SEK
2013-03-21 - Årsstämma
2013-02-08 - Kapitalmarknadsdag 2013
2013-01-25 - Bokslutskommuniké 2012
2012-10-17 - Analytiker möte 2012
2012-10-17 - Kvartalsrapport 2012-Q3
2012-07-11 - Kvartalsrapport 2012-Q2
2012-04-19 - Kvartalsrapport 2012-Q1
2012-03-29 - X-dag ordinarie utdelning GETI B 3.75 SEK
2012-03-28 - Årsstämma
2012-01-26 - Bokslutskommuniké 2011
2011-10-20 - Kvartalsrapport 2011-Q3
2011-07-11 - Kvartalsrapport 2011-Q2
2011-04-28 - X-dag ordinarie utdelning GETI B 3.25 SEK
2011-04-27 - Årsstämma
2011-04-27 - Kvartalsrapport 2011-Q1
2011-01-28 - Kapitalmarknadsdag 2011
2011-01-26 - Bokslutskommuniké 2010
2010-10-19 - Kvartalsrapport 2010-Q3
2010-04-23 - X-dag ordinarie utdelning GETI B 2.75 SEK
2010-04-22 - X-dag ordinarie utdelning GETI B 2.75 SEK
2010-04-21 - Årsstämma
2010-04-21 - Kvartalsrapport 2010-Q1
2010-01-26 - Bokslutskommuniké 2009
2009-07-13 - Kvartalsrapport 2009-Q2
2009-05-06 - Kvartalsrapport 2009-Q3
2009-04-22 - X-dag ordinarie utdelning GETI B 2.40 SEK
2009-04-21 - Årsstämma
2009-04-21 - Kvartalsrapport 2009-Q1
2008-04-18 - X-dag ordinarie utdelning GETI B 2.40 SEK
2007-04-20 - X-dag ordinarie utdelning GETI B 2.20 SEK
2006-04-21 - X-dag ordinarie utdelning GETI B 2.00 SEK
2005-04-20 - X-dag ordinarie utdelning GETI B 1.65 SEK
2004-04-22 - X-dag ordinarie utdelning GETI B 1.35 SEK
2003-11-25 - Split GETI B 1:4
2003-04-24 - X-dag ordinarie utdelning GETI B 4.25 SEK
2002-04-19 - X-dag ordinarie utdelning GETI B 3.75 SEK
2001-04-24 - X-dag ordinarie utdelning GETI B 3.50 SEK
2000-04-28 - X-dag ordinarie utdelning GETI B 3.50 SEK
1999-04-22 - X-dag ordinarie utdelning GETI B 3.25 SEK
1998-04-24 - X-dag ordinarie utdelning GETI B 2.75 SEK
1997-04-30 - X-dag ordinarie utdelning GETI B 2.50 SEK
1996-04-19 - X-dag ordinarie utdelning GETI B 6.00 SEK

Beskrivning

LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Getinge är ett globalt medicintekniskt bolag som specialiserar sig på att tillhandahålla utrustning och IT-system till hälso- och sjukvården samt life science-industrin. Bolaget erbjuder bland annat lösningar för operationssalar, intensivvårdsavdelningar, steriliseringscentraler och läkemedelsutveckling. Bolaget grundades 1904 och har sitt huvudkontor i Göteborg.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-06-02 15:00:00

Getinge today announced the launch of the Vasoview Hemopro 3 Endoscopic Vessel Harvesting (EVH) System, including the Hemopro 3 Harvesting Tool and dedicated Hemopro 3 Power Supply. Designed for clinicians, by clinicians, the system represents the latest evolution of Getinge's EVH platform, enhancing decades of experience supporting coronary artery bypass grafting (CABG) procedures.

Endoscopic vessel harvesting is a minimally invasive technique used to obtain blood vessels, most commonly the saphenous vein or radial artery, for use in CABG surgery. Vessel harvesting plays a critical role in procedural success, as conduit quality and incision-related complications can significantly impact outcomes and recovery. Compared with traditional open harvesting methods, EVH has been associated with reduced wound complications, less postoperative pain, faster recovery, and improved cosmetic results.1,2

"For nearly three decades, the Vasoview family has helped set the standard in EVH," said Elin Frostehav, President, Acute Care Therapies at Getinge. "Vasoview Hemopro 3 builds on that legacy with thoughtful design enhancements shaped by real-world clinician experience, reinforcing our long-standing commitment to innovation in EVH." 

Getinge has completed an Initial Launch of the Vasoview Hemopro 3 EVH System and has received valuable, positive customer feedback. Getinge has continuously refined EVH technology with a focus on preserving conduit quality while improving the patient and clinician experience. Through close collaboration with vessel harvesting specialists, Getinge has advanced EVH technology in a deliberate, user-driven way, ensuring solutions evolve alongside clinical practice. 

The Vasoview Hemopro 3 system incorporates targeted enhancements across ergonomics, energy control, visualization, and workflow efficiency, informed by input from more than 100 vessel harvesting specialists worldwide. A redesigned Harvesting Tool features an ergonomic, game-controller-style handle and a soft-touch Activation Toggle that allows activation with minimal force and multiple hand positions, supporting clinician comfort and control throughout the procedure. 

The system also introduces simplified connectivity through an integrated Harvesting Tool Power Cable, providing a one-click connection to the new Vasoview Hemopro 3 Power Supply and eliminating the need for extension cable sterilization. The dedicated Power Supply is designed to deliver consistent energy and promote efficient cut-and-cautery performance with minimal downtime. Hemopro 3 includes features which support consistent visibility, safety, and workflow efficiency during EVH. 

"With Hemopro 3, we focused on delivering meaningful improvements that enhance the patient experience and ultimately support better outcomes - safely, reliably, and consistently," says Cynthia Hougum, Vice President, Cardiovascular Surgery at Getinge. 

Vasoview Hemopro 3 is launching in the U.S., with a training supported rollout available for U.S. customers. Getinge plans a phased expansion outside the U.S., with availability in additional markets to follow based on regulatory approvals and market readiness. Vasoview Hemopro 2 will continue to be available as Getinge rollout availability of Vasoview Hemopro 3.

For more information on Vasoview Hemopro 3 and Getinge's full portfolio of medical solutions, visit  Product Catalog - Getinge.

1. Ferdinand FD, MacDonald JK, Balkhy HH, et al. Endoscopic Conduit Harvesting in Coronary Artery Bypass Grafting Surgery: An ISMICS Systematic Review and Consensus Conference Statements. Innovations. 2017; 12(5): 301-319 

2. Luckraz, H., et al., Endoscopic vein harvest in patients at high risk for leg wound complications: A cost-benefit analysis of an initial experience. Am J Infect Control, 2016. 44(12): p. 1606-1610.  

Media contact:
Caroline Örmgård, Head of Public & Media Relations
Phone: +46 (0)10 335 0041
Email: caroline.ormgard@getinge.com

About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs approximately 12,000 people worldwide and the products are sold in more than 135 countries.